Janssens R, Struyf S, Proost P
One of the cleaner ones, a 24-week randomized study of 279 mild-to-moderate Alzheimers patients, tested three doses against placebo and found a result no marketer would have designed: the lowest dose, 10 mL a day, beat placebo on both a cognitive scale and a global clinical rating, while the higher 30 and 60 mL doses improved the global rating but not cognition (Alvarez et al., Eur J Neurol 2006, randomized controlled trial)
Because of this, the majority of studies looking at cysteine supplementation on endogenous antioxidant up-regulation use NAC, which endogenously cleaves cystine into two cysteine molecules [77]
Klinics insurance expertise also ensures this choice becomes seamless within our Auburn programs
doi:10.1530/erc-23-0319 European Medicines Agency
Accessed June 12, 2020